AlloSource Scientists Contribute to NASA’s Jet Propulsion Laboratory Study on Antimicrobial Survivability on the International Space Station

Centennial, Colo. — December 10, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, served as a contributing science team to NASA’s Jet Propulsion Laboratory’s (JPL) scientific study on further antimicrobial survivability on the International Space Station (ISS). The science and results were highlighted in the recently published article titled “Multi-drug resistant Enterobacter bugandensis species isolated from the International Space Station and comparative genomic analyses with human pathogenic strains” in BMC Microbiology. As a follow-up to a previous study, which used molecular methods to characterize genes from ISS environmental samples, this…

AlloSource Granted Patent for Proprietary Laser Cutting Enclosure

Centennial, Colo. — November 16, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, received U.S. patent 10,105,793, titled Enclosure for laser cutting of human tissue. This patent encompasses AlloSource’s method of producing a closed system that allows a laser beam to pass through and etch allograft tissue, while maintaining a sterile barrier. The proprietary method expedites processing, maximizes the use of tissue, and allows utilization of a specialized laser technology in a clean room setting. The process is used to create ProChondrix® CR, AlloSource’s fresh cryopreserved osteochondral allograft. ProChondrix CR…

AlloSource Announces Two Presentations at the North American Spine Society Annual Meeting

Centennial, Colo. — September 25, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced two presentations on the use of biologics in spinal fusion surgery at AlloSource’s booth #2031 at the North American Spine Society (NASS) Annual Meeting on Thursday, September 27. Dr. Wellington K. Hsu will present on Novel Allograft Processing Methods to Improve Osteoinductivity and Clinical Outcomes at 12:10 p.m. Dr. Hsu is a Professor of Orthopaedic Surgery and Neurological Surgery at Northwestern University Feinberg School of Medicine in Chicago, Illinois and specializes in degenerative spine surgery, cervical spine surgery,…

AlloSource Named One of the 100 Healthiest Workplaces in America by Healthiest Employers

Centennial, Colo. — September 21, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that Healthiest Employers® named AlloSource one of the 100 Healthiest Workplaces in America. Over 1,000 organizations across the United States applied for the award, which measures employees on six essential values: vision, culture/engagement, learning, expertise, metrics and technology. Healthiest Employers’ annual “Healthiest 100 Workplaces in America” program honors leaders in corporate wellness and rewards employers that demonstrate a strategic vision for their company’s role in the overall healthcare environment. “We are honored to receive this…

AlloSource Receives Gold Level Recognition for Workplace Health From the American Heart Association

Centennial, Colo. — August 9, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced it received Gold level recognition from the American Heart Association for promoting a workplace culture of health and wellbeing. The American Heart Association’s Workplace Health Achievement Index scores companies of all sizes on 55 best practices in seven categories: leadership, engagement, programs, policies and environment, partnerships, communications, and reporting outcomes. The AHA created the Index in collaboration with its CEO Roundtable members from some of America’s largest companies who are committed to applying evidence-based approaches…

AlloSource Awards Dr. Kevin Shea the Annual Dr. Steven Gitelis Inspiration Award

Centennial, Colo. — July 17, 2018 — AlloSource, one of the largest nonprofit cellular and tissue networks in the country, offering life-saving and life-enhancing solutions in orthopedic, spine, burn and wound procedures to help restore patient health and mobility, today announced that it will award Dr. Kevin Shea with its second annual Dr. Steven Gitelis Inspiration Award. The award honors a doctor or clinician that inspires AlloSource through his or her work in treating patients with allografts. Dr. Shea recently joined the Stanford University School of Medicine as a professor of orthopedic surgery and also serves as director of the…

AlloSource Partners With Tuition.io to Help Employees Pay Down Student Debt

Centennial, Colo. — May 1, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced the rollout of its student loan repayment assistance program, a new employee benefit to help workers pay off their student loans faster. The company is partnering with Tuition.io, the leading platform for employee student loan contributions, to administer the program. As part of the benefit, AlloSource employees will receive monthly contributions to help pay down the principal of their student loans. According to Willis Towers Watson, only 4% of companies in the United States offer…

AlloSource Announces Two Presentations on ProChondrix at the International Cartilage Repair Society World Congress

Centennial, Colo. — April 10, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that clinical and scientific data on its ProChondrix® osteochondral allograft will be presented at the International Cartilage Repair Society’s 14th World Congress on Wednesday, April 11 from 13:00-14:00 in the Almaty 3 Room. Dr. Vishal Mehta will present his 24-month clinical experience with ProChondrix in the knee. Dr. Mehta performed the first ProChondrix implantation in December of 2014 and will share his clinical experience with the product. “ProChondrix has been a valuable addition to my…

AlloSource and Stryker Launch ProChondrix CR Cryopreserved Osteochondral Allograft

Centennial, Colo. – April 4, 2018 – AlloSource and Stryker today announced the launch of ProChondrix® CR, a cryopreserved osteochondral allograft. ProChondrix CR is a single-stage, natural solution for patients in need of articular cartilage repair. ProChondrix CR is designed to match biomechanical and biochemical properties of normal hyaline cartilage, restore a smooth articular cartilage surface, help relieve patient symptoms, and improve function. AlloSource launched ProChondrix in 2016 and developed a cryopreserved version to provide a longer shelf-life, while maintaining the high cellular viability of the product1. “ProChondrix CR demonstrates our commitment to innovation and our surgeon customers,” said Kerr…